Senate Democrats Demand Details on Pentagon's Testosterone Screening Policy
Senate Democrats are pressing Defense Secretary Pete Hegseth for details on the Pentagon's recently announced testosterone screening policy for military personnel. The policy, unveiled on July 15, 2026, mandates annual testosterone deficiency screenings for service members aged 30 and older as part of their periodic health assessments. Troops under 30 may opt in voluntarily.
In a letter sent on July 20, 2026, Democratic Senators Richard Blumenthal (CT), Mazie Hirono (HI), Gary Peters (MI), Elizabeth Warren (MA), and Ruben Gallego (AZ) demanded specifics about the policy's implementation and scientific rationale. They raised concerns about the lack of scientific support or medical justification for the screenings, questioning how the policy would improve military readiness or health outcomes.
The senators also highlighted potential equity issues, noting that the policy might undermine efforts to ensure female service members are evaluated based on mission performance. They pointed out that routine care for conditions like perimenopause or menopause remains under-resourced.
Additional concerns include the development process of the policy, resource capacity for safe implementation, management of medical privacy, and the potential use of external contractors or vendors. The Pentagon has not yet clarified key details such as the thresholds for defining testosterone deficiency, applicability to female service members, or budgetary and procedural logistics.
Medical guidelines, such as those from the Endocrine Society, typically advise against routine testosterone screening without symptoms, recommending diagnosis based on symptoms and multi-test confirmation. Fewer than 6% of men aged 30 to 79 have both testosterone deficiency and symptoms, according to available data.